Citation Tools

Original research
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal

Download to a citation manager

Cite this article as:
Isoyama S, Mori S, Sugiyama D, et al
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal